About Dr. Garvit Chitkara

• Designation: Senior Consultant
• Languages Spoken: Hindi, English, Punjabi

Dr Garvit Chitkara has 15+ years of experience as a doctor and has been practicing Breast Surgical oncology for a decade. After getting trained in breast oncology from Tata Memorial hospital he practiced as Consultant Breast surgeon at TMH and has also trained many students.

Dr Chitkara’ s interests are breast oncoplastic surgeries and his mission is to provide comprehensive breast care to all patients in an environment that is safe, reassuringly pleasant and comfortable. Apart from his love for cancer care, he is also an avid reader, a movie buff, a doting father to his two young boys and a loving husband.

Previous Experience:

Research and Publications

1. 1. Organ preservation in splenic abscess-a case report Case report Med J Armed Forces India. 2014 Apr;70(2):195-7
   2. Corrosive Tracheoesophageal fistula following button battery ingestion Case report Indian Pediatr.2102feb,49(2);145-6
   3. Non manipulative relief for chronic back pain Rapid Response BMJ
   4. Study of orofacial response to manually dexterous task in mentally disabled children Paper presentation IAPSM
   5. Abdominoelectrography Proceedings Intelligent system and communications 2005, Manipal
   6. Lymphnode ratio as an alternative to pN staging in node positive breast cancer Poster Presentation ISMPO 2015
   7. Low axillary sampling in women with clinically node negative breast cancer post neoadjuvant chemotherapy: a retrospective study Poster Presentation Advances in breast Cancer 2016, Mumbai
   8. Low axillary sampling in women with clinically node negative breast cancer post neoadjuvant chemotherapy: a retrospective study Oral presentation Advances in breast Cancer 2016, Mumbai
   9. Phyllodes : A Retrospective Audit Oral Presentation 2nd Indian cancer congress , Bangalore
   10. Management of breast cancer Chapter Text book of clinical oncology in the Indian context
   11. Inflammatory Breast Cancer Chapter Roshan Lall Gupta’s Recent Advances in Surgery 17th edition 2021
   12. Clinical Benefit of Circulating Tumor DNA Analysis in Early-Stage Breast Cancer Letter to the editor JAMA Oncology. 10.1001/jamaoncol.2019.5677
   13. Tale of constant adaptation, revision, and change of cancer therapy during the ongoing COVID crisis: Adapting to cope and win Article Indian Journal of Medical and Pediatric Oncology(Vol. 41, Issue 2)
   14. Validation of nomograms to predict nonsentinel lymph node metastasis after positive sentinel lymph node in breast cancer: Indian cohort background. Conference abstract ASCO Journal of Clinical Oncology 2020 38:15_suppl, 56 8-568
   15. En Bloc Excision of Phyllodes Tumor of the Breast: Radical Approach Heralds Better Outcome Original research Article Clinical Breast Cancer,2020

1. Knowledge attitude and practice of surgeons for breast conserving surgery: Results from an Indian cohort Article European Journal of Cancer, 10.1016/S0959-8049(20)30611- 0
2. Access to HER2-targeted therapy at a tertiary care center in India: An evolution Article Indian J Cancer. 2021 Mar 21. doi: 10.4103/ijc.IJC_841_19. Epub ahead of print. PMID: 33753630.
3. Clinical course and outcome of patients with COVID-19 in Mumbai City: an observational study Article BMJ Open 2021;11:e042943. doi: 10. 1136/bmjopen-2020-042943
4. Reproductive factors and gall-bladder cancer, and the effect of common genetic variants on these associations: a case-control study in India.
5. Phyllodes Tumour: A single institution retrospective audit of 433 cases
6. Abstract P4-05-14: Validation of PREDICT version 2.2 on a retrospective cohort of Indian women with operable breast cancer
7. 90PIntraoperative frozen section analysis of lymph nodes in women undergoing axillary sampling for treatment of Ca breast
8. PO-1090 Tumor bed boost volume delineation and planning post-oncoplasty following multidisciplinary approach
9. Abstract OT1-08-01: Concurrent versus sequential chemo-endocrine therapy in er positive and her2 negative non-metastatic breast cancer- an open-label, phase III, randomized controlled trial
10. Molecular Biology in the Breast Clinics— Current status and future perspectives